|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date26 May 2021 |
|
Mechanismκ opioid receptor agonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date15 May 1979 |
盐酸纳布啡注射液单次和多次静脉给药在中国健康人体的药代动力学试验
[Translation] Pharmacokinetic study of single and multiple intravenous administration of nalbuphine hydrochloride injection in healthy Chinese subjects
评价盐酸纳布啡注射液单次和多次静脉注射给药在健康受试者体内的药代动力学特征和安全性。
[Translation] To evaluate the pharmacokinetic characteristics and safety of single and multiple intravenous injections of nalbuphine hydrochloride injection in healthy subjects.
一项评价注射用磷酸左奥硝唑酯二钠在腹腔感染手术患者中的药代动力学试验
[Translation] A study evaluating the pharmacokinetics of levo-ornidazole disodium phosphate for injection in surgical patients with intra-abdominal infection
评价注射用磷酸左奥硝唑酯二钠在腹腔感染手术患者中的药代动力学特征和安全性。
[Translation] To evaluate the pharmacokinetic characteristics and safety of levornidazole disodium phosphate for injection in surgical patients with intra-abdominal infection.
一项评价注射用磷酸左奥硝唑酯二钠在不同程度肾功能不全受试者中的药代动力学和安全性的开放、平行、单次给药的临床试验
[Translation] An open, parallel, single-dose clinical trial to evaluate the pharmacokinetics and safety of levonidazole disodium phosphate for injection in subjects with varying degrees of renal insufficiency
评价注射用磷酸左奥硝唑酯二钠单次静脉给药在中、重度肾功能不全受试者和健康受试者中的药代动力学特征和安全性。
[Translation] To evaluate the pharmacokinetic characteristics and safety of single intravenous administration of levonidronate disodium phosphate for injection in subjects with moderate to severe renal impairment and healthy subjects.
100 Clinical Results associated with Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co.,Ltd.
0 Patents (Medical) associated with Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co.,Ltd.
100 Deals associated with Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co.,Ltd.
100 Translational Medicine associated with Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co.,Ltd.